An Ontario study of 491 women with invasive ovarian cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk. Dr. Kelly Metcalfe, an associate professor at the University of Toronto's Lawrence S.
More...
Threaded Mode